Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Dutcher

Showing results (11-20 of 151) with videos related to

Pageof 16
Sort By:
Current Oncology Reports|June 8, 2001
Angiogenesis and melanomaJ P Dutcher
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1984
Re: Decreased sensitivity of early imaging with in-111 oxine-labeled leukocytes in detection of occult infectionJ P Dutcher
Journal of Cancer Research and Clinical Oncology|April 6, 1999
A phase II trial of dose-intensive interleukin-2 in metastatic renal cell carcinomaL Oleksowicz, J P Dutcher
Medical Oncology (Northwood, London, England)|June 1, 1995
Adhesive receptors expressed by tumor cells and platelets: novel targets for therapeutic anti-metastatic strategiesL Oleksowicz, J P Dutcher
Current Treatment Options in Oncology|June 12, 2002
Accelerated and blastic phase of chronic myeloid leukemiaJ P Dutcher, P H Wiernik
Seminars in Oncology|December 1, 1993
The role of recombinant interleukin-2 in therapy for hematologic malignanciesJ P Dutcher, P H Wiernik
Leukemia|January 1, 1992
Clinical importance of anthracyclines in the treatment of acute myeloid leukemiaP H Wiernik, J P Dutcher
Cancer Treatment and Research|January 19, 1999
Novel biologic approaches to hematologic malignanciesJ P Dutcher, P H Wiernik
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1988
Extension of remission in acute nonlymphocytic leukemiaJ P Dutcher, P H Wiernik
Cancer|May 15, 1984
Long-term survival of a patient with multiple myeloma--a cure? A case reportJ P Dutcher, P H Wiernik
Pageof 16

Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
Current Oncology Reports|June 8, 2001
Angiogenesis and melanomaJ P Dutcher
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1984
Re: Decreased sensitivity of early imaging with in-111 oxine-labeled leukocytes in detection of occult infectionJ P Dutcher
Journal of Cancer Research and Clinical Oncology|April 6, 1999
A phase II trial of dose-intensive interleukin-2 in metastatic renal cell carcinomaL Oleksowicz, J P Dutcher
Medical Oncology (Northwood, London, England)|June 1, 1995
Adhesive receptors expressed by tumor cells and platelets: novel targets for therapeutic anti-metastatic strategiesL Oleksowicz, J P Dutcher
Current Treatment Options in Oncology|June 12, 2002
Accelerated and blastic phase of chronic myeloid leukemiaJ P Dutcher, P H Wiernik
Seminars in Oncology|December 1, 1993
The role of recombinant interleukin-2 in therapy for hematologic malignanciesJ P Dutcher, P H Wiernik
Leukemia|January 1, 1992
Clinical importance of anthracyclines in the treatment of acute myeloid leukemiaP H Wiernik, J P Dutcher
Cancer Treatment and Research|January 19, 1999
Novel biologic approaches to hematologic malignanciesJ P Dutcher, P H Wiernik
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1988
Extension of remission in acute nonlymphocytic leukemiaJ P Dutcher, P H Wiernik
Cancer|May 15, 1984
Long-term survival of a patient with multiple myeloma--a cure? A case reportJ P Dutcher, P H Wiernik
Pageof 16